Home › Forums › Pharmacovigilance Forum › Identifying Psychological Disorders and Symptoms as AEs › Reply To: Identifying Psychological Disorders and Symptoms as AEs
Please note, that the response to your query represents the opinions formed from a consensus of the PIPA Committee, but do not represent their employing companies. These responses are intended as guidance. Please also refer to pharmacovigilance regulatory legislation, guidelines and your own company procedures.
Thank you for your enquiry regarding identifying psychological disorders and symptoms as AEs.
In response to your question, would a normal emotional response, e.g. anxiety, to a situation (such as a delayed delivery of their medication) be reportable?
There are a few factors to consider here and the below outlines what would and would not be considered reportable. Please do take these into consideration when assessing which situation this falls into.
The following situation is not deemed as reportable AE:
– If the anxiety is caused by waiting for a delivery
However the following situations are deemed as reportable AEs:
– Has the patient experienced anxiety or any other form of a psychiatric-related disorder from taking the prescribed medicine in question?
– How long has the delivery been delayed which could have resulted in the patient experiencing an AE from not taking their medication.
I do hope this has helped in responding to your query.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.